Amissa Inc SBIR Phase I award

Department of Health and Human Services, through National Institutes of Health, awarded Amissa Inc of Charlotte, NC $504,222 under the SBIR program (Phase I), with work starting 2026-08-17 and running to 2027-07-30. It is one of 2 SBIR and STTR awards Amissa Inc received in the last two years, $817,433 in all. Each figure links to the federal record.

The award

Want the whole picture on Amissa Inc?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Amissa Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Amissa Inc covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

What it is for

Hermosa: Understanding the perimenopausal health experience of latina women using digital biomarkers from apple watch. - perimenopause remains one of the most under-researched, under-diagnosed, and under-treated conditio

Funding actions on this award

Hermosa: Understanding the perimenopausal health experience of latina women using digital biomarkers from apple watch. - perimenopause remains one of the most under-researched, under-diagnosed, and under-treated conditions in medicine. Vasomotor symptoms (vms)—including hot flashes and night sweats—affect approximately 70% of women and often persist for over seven years, significantly disrupting sleep, mood, and quality of life. Latina women, in particular, experience more frequent, severe, and longerlasting vms than other women, yet they remain less represented in menopause-related clinical research and less likely to access evidence-based care such as hormone therapy. There is an urgent need for personalized and scalable tools to evaluate and manage menopause-related symptoms. This Phase I SBIR project will support the development of digital biomarkers to detect and monitor vms in perimenopausal latina women using physiological data collected via the apple watch. Amissa health has developed the first—and only—clinical-grade perimenopausal health monitoring application with access to raw apple watch sensor data through apple’s sensorkit. This platform enables continuous, passive data collection—including skin temperature, heart rate, movement, and sleep—alongside selfreported symptom tracking via a mobile app. Unlike traditional symptom diaries and in-clinic assessments, this ...

From the federal award record.

Other SBIR and STTR awards to Amissa Inc

Where this comes from

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.

Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.

All SBIR and STTR awards